TAILIEUCHUNG - Exploring Challenges, Progress, and New Models for ENGAGING THE PUBLIC in the CLINICAL RESEARCH ENTERPRISE Clinical Research Roundtable Workshop Summary

The Institute of Medicine convened the Clinical Research Roundtable (CRR) in early 2000 to provide a forum for stakeholders to discuss approaches to resolving both acute and long-term issues affecting the Clinical Research Enterprise. It strives to enhance mutual understanding of clinical research between the scientific community and the general public, while improving the public’s understanding of and participation in clinical studies. The stakeholders involved in the CRR include individuals from the academic health community, federal agencies sponsoring and regulating clinical research, private-sector sponsors of clinical research, foundations, public- and private-sector insurance programs, health plans and insurance companies, corporate purchasers of health care, and representatives of patient interests | Exploring Challenges Progress and New Models for ENGAGING THE PUBLIC in the CLINICAL RESEARCH INSTITUTE OF MEDICINE Of me NATIONAL ACADEMICS Clinical Research Roundtable Workshop Summary Exploring Challenges Progress and New Models for ENGAGING THE PUBLIC clinical n RESEARCH ENTERPRISE Clinical Research Roundtable Workshop Summary Based on a Workshop of the Clinical Research Roundtable Board on Health Sciences Policy Jessica Aungst Amy Haas Alexander Ommaya Lawrence W. Green Editors INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington . THE NATIONAL ACADEMIES PRESS 500 Fifth Street . Washington DC 20001 NOTICE The project that is the subject of this report was approved by the Governing Board of the National Research Council whose members are drawn from the councils of the National Academy of Sciences the National Academy of Engineering and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. Support for this project was provided by the Agency for Health Care Research and Quality American Medical Association Association of American Medical Colleges BlueCross BlueShield Association Burroughs Wellcome Fund Centers for Disease Control and Prevention Centers for Medicare and Medicaid Services formerly HCFA Department of Veterans Affairs Doris Duke Charitable Foundation Food and Drug Administration Johnson Johnson Merck and Company National Institutes of Health Pfizer Inc. and the Robert Wood Johnson Foundation. The views presented in this report are those of the authors and are not necessarily those of the funding agencies. International Standard Book Number 0-309-08946-8 book International Standard Book Number 0-309-51726-5 PDF Library of Congress Control Number 2003107016 Additional copies of this report are available from the National Academies Press 500 Fifth Street . Lockbox 285 Washington DC 20055

TÀI LIỆU HOT